The title compound, C 2 H 3 N 3 OS, is a monoclinic (P2 1 /c) polymorph of the previously reported triclinic structure [Kang et al. (2012) . Acta Cryst. E68, o1198]. The asymmetric unit contains two independent molecules which are essentially planar, with r.m.s. deviations of 0.001 and 0.032 Å from the mean plane defined by the seven non-H atoms. In the crystal, N-HÁ Á ÁN and N-HÁ Á ÁO hydrogen bonds link the molecules into a sheet parallel to (111).
Related literature
For structures and reactivity of thiadiazole derivatives, see: Parkanyi et al. (1989) ; Cho et al. (1996) . For the triclinic polymorph, see; Kang et al. (2012) . Table 1 Hydrogen-bond geometry (Å , ). 
Experimental

Crystal data
Data collection: SMART (Bruker, 2002 ); cell refinement: SAINT (Bruker, 2002) ; data reduction: SAINT; program(s) used to solve structure: SHELXS2013 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL2013 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) ; software used to prepare material for publication: WinGX (Farrugia, 2012) .
S1. Chemical context
S2. Structural commentary
5-Amino-2H-1,2,4-thiadiazolin-3-one heterocycle is an analog of cytosine (Parkanyi et al., 1989) . Derivatives of this heterocyclic compound are interesting in the antibacterial activity, potential carcinogenicity, and kinase inhibitor activity (Cho et al., 1996) . The title compound, 5-amino-1,3,4-thiadiazol-2(3H)-one (I) is an isomer of 5-amino-2H-1,2,4-thiadiazolin-3-one, which has become an attractive moiety due to potential biological activities. These heterocyclic compounds are potentially good ligands because of N, O, and S atoms which are good donor atoms to both transition metals (Cu, Zn, Cd) and lanthanide metals (Tb and Eu). In our interest to metal complexes with these heterocyclic compounds, the title compound was isolated accidently. (Table 1 and Fig. 2 ).
S3. Supramolecular features
S4. Database survey
S5. Synthesis and crystallization
The title compound (I) was synthesized by the process of the previous report (Kang et al. 2012) . Copper(II) chloride (1.36 g, 8 mmol) dissolved in ethanol, was added drop wise to a stirred ethanolic solution containing 5-amino-1,3,4-thiadiazol-2(3H-one (1.87 g, 16 mmol). The mixture was stirred for 10 h at room temperature. The resulting solution was filtered and allowed to stand at room temperature. Colourless crystals of (I) were obtained at room temperature over a period of a few weeks.
S6. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 1 127.9 (3) O13-C9-N10 126.7 (3) O6-C2-S1
125.5 (2) O13-C9-S8 125.7 (2) N3-C2-S1
106.5 (2) N10-C9-S8 107.6 (2) C2-N3-N4 120.0 (3) C9-N10-N11 118.9 (3) C2-N3-H3 123 (2) C9-N10-H10 118 (2)
